| 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart … TA McDonagh, M Metra, M Adamo, RS Gardner, A Baumbach, M Böhm, ... European heart journal 42 (36), 3599-3726, 2021 | 9398 | 2021 |
| How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and … WJ Paulus, C Tschöpe, JE Sanderson, C Rusconi, FA Flachskampf, ... European heart journal 28 (20), 2539-2550, 2007 | 3883 | 2007 |
| A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial … WJ Paulus, C Tschöpe Journal of the American College of Cardiology 62 (4), 263-271, 2013 | 3335 | 2013 |
| Clinical features and outcomes of takotsubo (stress) cardiomyopathy C Templin, JR Ghadri, J Diekmann, LC Napp, DR Bataiosu, ... New England Journal of Medicine 373 (10), 929-938, 2015 | 2452 | 2015 |
| How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the … B Pieske, C Tschöpe, RA De Boer, AG Fraser, SD Anker, E Donal, ... European heart journal 40 (40), 3297-3317, 2019 | 1442 | 2019 |
| Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial F Edelmann, R Wachter, AG Schmidt, E Kraigher-Krainer, C Colantonio, ... Jama 309 (8), 781-791, 2013 | 845 | 2013 |
| Myocarditis and inflammatory cardiomyopathy: current evidence and future directions C Tschöpe, E Ammirati, B Bozkurt, ALP Caforio, LT Cooper, SB Felix, ... Nature Reviews Cardiology 18 (3), 169-193, 2021 | 807 | 2021 |
| Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler … M Kasner, D Westermann, P Steendijk, R Gaub, U Wilkenshoff, ... Circulation 116 (6), 637-647, 2007 | 791 | 2007 |
| Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction D Westermann, D Lindner, M Kasner, C Zietsch, K Savvatis, F Escher, ... Circulation: Heart Failure 4 (1), 44-52, 2011 | 665 | 2011 |
| Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology PM Seferović, MC Petrie, GS Filippatos, SD Anker, G Rosano, ... European journal of heart failure 20 (5), 853-872, 2018 | 649 | 2018 |
| Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF) S Fülster, M Tacke, A Sandek, N Ebner, C Tschöpe, W Doehner, ... European heart journal 34 (7), 512-519, 2013 | 621 | 2013 |
| Crosstalk between fibroblasts and inflammatory cells S Van Linthout, K Miteva, C Tschöpe Cardiovascular research 102 (2), 258-269, 2014 | 597 | 2014 |
| Role of left ventricular stiffness in heart failure with normal ejection fraction D Westermann, M Kasner, P Steendijk, F Spillmann, A Riad, K Weitmann, ... Circulation 117 (16), 2051-2060, 2008 | 547 | 2008 |
| Myocardial microvascular inflammatory endothelial activation in heart failure with preserved ejection fraction C Franssen, S Chen, A Unger, HI Korkmaz, GW De Keulenaer, C Tschöpe, ... JACC: Heart Failure 4 (4), 312-324, 2016 | 529 | 2016 |
| Management of acute myocarditis and chronic inflammatory cardiomyopathy: an expert consensus document E Ammirati, M Frigerio, ED Adler, C Basso, DH Birnie, M Brambatti, ... Circulation: Heart Failure 13 (11), e007405, 2020 | 494 | 2020 |
| The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements C Tschöpe, M Kašner, D Westermann, R Gaub, WC Poller, ... European heart journal 26 (21), 2277-2284, 2005 | 487 | 2005 |
| Inflammation–cause or consequence of heart failure or both? S Van Linthout, C Tschöpe Current heart failure reports 14, 251-265, 2017 | 437 | 2017 |
| Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society … S Heymans, E Hirsch, SD Anker, P Aukrust, JL Balligand, ... European journal of heart failure 11 (2), 119-129, 2009 | 431 | 2009 |
| New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes M Senni, WJ Paulus, A Gavazzi, AG Fraser, J Díez, SD Solomon, ... European heart journal 35 (40), 2797-2815, 2014 | 411 | 2014 |
| Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism D Westermann, S Rutschow, S Jager, A Linderer, S Anker, A Riad, ... Diabetes 56 (3), 641-646, 2007 | 400 | 2007 |
